Summary
- Current Price
- As of today, APLS price is $17.57, up +2.09% on
- Current Price All-Time High
- APLS price is currently -81.46% below its historical high of $94.75 set on
- Market Cap
- APLS current market cap is $2B, down -26.63% year-over-year
- PE Ratio
- APLS current PE ratio is 142.27
- Revenue
- APLS current annual revenue is $1.00B, up +28.46% year-over-year
- Next Earnings
- The next earnings release for APLS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Apellis Pharmaceuticals, Inc. |
| Ticker | NASDAQ: APLS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | apellis.com |
| Employees | 705 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $17.57 | |
| Price, 1D Change | +2.09% | |
| $2B | ||
| - | ||
| 142.27 | ||
| 0.88 | ||
| $1B | ||
| Revenue, 1Y Change | +28.46% | |
| $0.17 | ||
| EPS, 1Y Change | +110.80% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.17 | ||
| EPS Estimate | N/A | -$1.22 |
| EPS Est. Change | N/A | -806.96% |
| $1.00B | ||
| Revenue Estimate | N/A | $861.51M |
| Revenue Est. Change | N/A | -14.17% |
| Current Price | $17.57 | |
| Price Target | - | $29.50 |
| Price Tgt. Change | - | +67.90% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.71 | -$1.60 | +6.88% | |
| $0.26 | $0.17 | -33.18% | |
| -$1.22 | N/A | -806.96% | |
| -$0.28 | N/A | -264.50% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $766.26M | $781.37M | +1.97% | |
| $1.00B | $1.00B | -0.09% | |
| $861.51M | N/A | -14.17% | |
| $1.02B | N/A | +1.89% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $17.57 | |
| $22.48 | ||
| SMA 200 vs Price | +27.94% | |
| $21.20 | ||
| SMA 50 vs Price | +20.68% | |
| 0.88 | ||
| $0.90 | ||
| 29.43 | ||
| 44.72% | ||
| 64.03% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $1.00B | ||
| $0.17 | ||
| $901.55M | ||
| 89.81% | ||
| $55.43M | ||
| 5.52% | ||
| $22.39M | ||
| 2.23% | ||
| $56.99M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 1.28 | ||
| 3.14 | ||
| 2.70 | ||
| - | ||
| 7 | ||
| -0.16 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 142.27 | ||
| 2.21 | ||
| 6.01 | ||
| 39.13 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $370.15M | ||
| $467.76M | ||
| $1.08B | ||
| $1.01B | ||
| $705.11M | ||
| $323.60M | ||
| $474.36M | ||
| $100.75M | ||
| $56.80M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $981.39M | ||
| $846.12M | ||
| $102.24M | ||
| $0.00 | ||
| $1.56M | ||
| $0.00 | ||
| $1.72M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $45.33M | ||
| -$313.00K | ||
| $8.88M | ||
| $313.00K | ||
| $45.01M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| William Blair | ||
| Scotiabank | ||
| Wells Fargo | → | |
| Baird | → | |
| Needham | → | |
| Mizuho | → | |
| JP Morgan | → | |
| JP Morgan | → | |
| Wedbush | → | |
| UBS | → |
Analyst sentiment
Institutional ownership
Screeners with APLS
FAQ
What is the ticker symbol for Apellis Pharmaceuticals, Inc.?
The ticker symbol for Apellis Pharmaceuticals, Inc. is NASDAQ:APLS
Does Apellis Pharmaceuticals, Inc. pay dividends?
No, Apellis Pharmaceuticals, Inc. does not pay dividends
What sector is Apellis Pharmaceuticals, Inc. in?
Apellis Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Apellis Pharmaceuticals, Inc. in?
Apellis Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Apellis Pharmaceuticals, Inc. based in?
Apellis Pharmaceuticals, Inc. is headquartered in United States
When did Apellis Pharmaceuticals, Inc. go public?
Apellis Pharmaceuticals, Inc. initial public offering (IPO) was on November 9, 2017
Is Apellis Pharmaceuticals, Inc. in the S&P 500?
No, Apellis Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Apellis Pharmaceuticals, Inc. in the NASDAQ 100?
No, Apellis Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Apellis Pharmaceuticals, Inc. in the Dow Jones?
No, Apellis Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Apellis Pharmaceuticals, Inc. last earnings report?
Apellis Pharmaceuticals, Inc.'s most recent earnings report was on February 24, 2026
When does Apellis Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Apellis Pharmaceuticals, Inc. is May 7, 2026
Data Sources & References
- APLS Official Website apellis.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1492422/000119312526065179/0001193125-26-065179-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1492422/000119312526065179/0001193125-26-065179-index.htm
- APLS Profile on Yahoo Finance finance.yahoo.com/quote/APLS
- APLS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/apls